The indefinite delivery contract with ID 75D30124D19010 was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Moderna US, Inc. to provide COVID-19 mRNA vaccines. This multiple award contract has a ceiling value of $117,420,333.00 and a period of performance ending on May 31, 2025.
Moderna US, Inc., a subsidiary of Modernatx, Inc., is the prime contractor responsible for continued production and delivery of the mRNA-1273 coronavirus vaccine from its Cambridge, MA facility over a 15-month period ending February 2024. This contract builds on previous COVID-19 vaccine procurements managed by the Biomedical Advanced Research and Development Authority. Moderna also holds additional COVID-19 vaccine contracts with the Department of Health and Human Services and the Department of the Army, as well as multiple award Federal Supply Schedule contracts with the Department of Veterans Affairs and the CDC to provide pediatric and adult COVID-19 vaccines.
Generated 9/7/24, 9:41 AM